毕马威：2024年全球生命科学行业首席执行官展望报告（英文版）

While economic and geopolitical uncertainty remain, life sciences CEOs are confident that their organizations can outgrow the industry and the economy. One fifth expect to see impressive growth — earnings growth above 5 percent and one third expect headcount growth of 6 percent or more. To deliver that, they expect to drive growth both organically and inorganically. In part, our survey reveals that CEOs expect new technologies — generative AI in particular — to help unlock new growth and inno